Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Description
Mark W. Hahn is the Chief Financial Officer of Verona Pharma.
Mr. Hahn holds a Bachelor of Business Administration degree in Accounting and...
Investor Profile
Mark W. Hahn has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United Kingdom.
- Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United Kingdom (100%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Mark W. Hahn frequently co-invest with?
Which angels does Mark W. Hahn often collaborate with?
What are some of recent deals done by Mark W. Hahn?
Find More Investors Like Mark W. Hahn
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
